Vertex Pharmaceuticals Inc. closed 18.39% short of its 52-week high of $519.88, which the company reached on November 8th.
Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...
Vertex Pharmaceuticals Inc. closed $108.22 short of its 52-week high ($519.88), which the company achieved on November 8th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback